The present invention generally relates to non-human transgenic animals expressing human cellular markers, including CD20 and methods for using the animals to identify agents that are effective to deplete cells bearing human CD20. The transgenic animals are also useful to test safety and efficacy of anti-CD20 therapies.

 
Web www.patentalert.com

< Methods to treat conditions associated with insulin signaling dysregulation

< Methods and vectors for improving nucleic acid expression

> Transgenic mice containing MSK2 serine/threonine kinase gene disruptions

> Transgenic mice containing deubiquitinated enzyme gene disruptions
~ 00281